Oppenheimer Holdings Inc. — Q3 2014 Form 10-Q
Reporting period: Three and nine months ended September 30, 2014; financial statements are unaudited. Oppenheimer is a diversified securities and financial-services firm, including brokerage, asset management, investment banking, and FHA-insured commercial mortgage origination and servicing.
Financial performance
Amounts below are in millions, except per-share data and percentages.
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $244.7 | $243.4 | $749.5 | $726.4 |
| Income before taxes | $10.9 | $8.2 | $16.1 | $20.6 |
| Net income attributable to Oppenheimer | $4.5 | $5.2 | $6.1 | $11.7 |
| Diluted EPS | $0.31 | $0.37 | $0.43 | $0.83 |
| Operating cash flow | Not stated for quarter | Not stated for quarter | $13.7 | $22.9 |
- Q3 revenue was up 0.5% year over year; pretax income rose 33.5%, but net income attributable to Oppenheimer fell 14.6%, principally reflecting a higher income-tax provision ($6.3 million versus $2.7 million).
- Nine-month revenue increased 3.2%, while pretax income declined 21.5% and attributable net income declined 47.7%. Management cited a $19.7 million charge recorded in the first half related to SEC and FinCEN matters, as well as $3.5 million of costs associated with early debt retirement.
- Q3 revenue mix: commissions $110.9 million (down 7.8%); advisory fees $71.0 million (up 18.0%); investment banking $33.8 million (up 58.4%); interest $12.4 million (down 13.8%); principal transactions $4.3 million (down 58.7%); and other revenue $12.3 million (down 27.1%).
- Compensation was 65.9% of revenue in Q3 and 65.7% for the nine-month period, compared with 66.2% and 66.1%, respectively, in 2013. Nine-month total expenses increased 3.9% to $733.4 million.
Balance sheet, debt and liquidity
- At September 30, 2014, total assets were $2.876 billion, down 2.6% from year-end 2013; total liabilities were $2.343 billion and total stockholders’ equity was $532.6 million.
- Cash and cash equivalents were $77.9 million, down from $98.3 million at December 31, 2013. Nine-month cash declined $20.4 million: operating activities provided $13.7 million, investing activities used $3.4 million, and financing activities used $30.7 million.
- Senior secured notes outstanding were $150 million, bearing 8.75% and due April 2018. The company redeemed or retired $50 million in April 2014; it reported compliance with note covenants. Bank call loans were $135.5 million, compared with $118.2 million at year-end. Repurchase-agreement liabilities were $688.3 million.
- Management said operating funds, capital and available credit facilities should meet foreseeable liquidity needs, while noting funding availability depends partly on market conditions. Oppenheimer’s regulatory net capital was $157.9 million, $131.2 million above its minimum requirement.
Material changes and business trends
- Advisory-fee and investment-banking growth supported results; commissions weakened amid lower retail transaction volumes. Trading profits and other revenue also declined year over year.
- Q3 segment results: Private Client revenue $142.6 million and pretax income $18.9 million; Asset Management $24.8 million and $8.3 million; Capital Markets $71.2 million and $5.7 million; Commercial Mortgage Banking $6.3 million and $1.8 million. Commercial Mortgage Banking revenue fell 31.8%, reflecting fewer and smaller loan originations.
- Client assets under administration were $88.3 billion, up 7.9% year over year; assets under management were $26.0 billion, up 9.2%. Financial-adviser headcount was 1,353, down from 1,400 a year earlier.
- The company retired $50 million of notes early, reducing stated annual interest costs by $3.9 million beginning in Q2 2014. It paid a quarterly dividend of $0.11 per share and declared the same amount for payment in November 2014.
Outlook, risks and unusual items
- No specific earnings or revenue guidance was provided. Management’s stated long-term priorities include recruiting experienced advisers, growing asset management and capital-markets capabilities, improving technology and pursuing suitable acquisitions.
- Management identified market volume and volatility, interest rates, competition, regulatory change, funding access, legal exposure and cybersecurity as important business risks. It stated that increased regulation and compliance demands may raise costs.
- Legal and regulatory exposure remains significant. The company estimated a possible aggregate loss range of $0 to approximately $33 million in excess of accruals for matters where it could estimate a range; some proceedings could not be reasonably estimated. The company said it was fully reserved for the SEC and FinCEN matters, subject to the outcome of discussions and possible enforcement actions.
- Auction-rate securities (ARS) remain a material contingent exposure. Oppenheimer held approximately $94.8 million principal value of ARS, carried at $87.3 million, and had $13.1 million of purchase commitments through 2016. Eligible clients held a further approximately $106.1 million of ARS potentially subject to future offers; those future offers were not recorded as commitments at quarter-end.
- After quarter-end, the company agreed to pay CIBC the disputed $25 million deferred purchase price and related costs; payment was made October 31, 2014, from amounts previously reserved and held in escrow. The company’s separate action against CIBC continued.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the nine-month period.
Important facts for investors to verify
- How much of the first-half $19.7 million regulatory charge will ultimately be required, and whether SEC or FinCEN enforcement actions or additional penalties will follow.
- The timing and scale of future ARS client purchase offers, client claims, issuer redemptions and resulting liquidity needs.
- The effect of the CIBC payment and continuing litigation on cash, reserves and any potential recovery.
- Whether advisory-fee growth can offset weaker commissions, trading revenue and commercial-mortgage originations.
- Availability and cost of short-term financing, including bank call loans, repurchase agreements and mortgage warehouse funding.